Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Race-based heart drug might stall search for better markers

Nature Medicine volume 11, page 812 (2005)Cite this article

BiDil's approval gives little incentive for companies to base drugs on biological markers rather than race, experts warn.

I would prescribe to non-African Americans who are already on standard therapy and not doing well . Flora Sam, Boston Medical Center

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Boston

    Emily Singer

Authors
  1. Emily Singer
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Scientists divided on relevance of race in medical research

Misreading race and genomics after BiDil

Related external links

BiDil

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singer, E. Race-based heart drug might stall search for better markers. Nat Med 11, 812 (2005). https://doi.org/10.1038/nm0805-812a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0805-812a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing